When people were randomised to receive either a placebo or Ozempic, they became biologically younger with the latter drug ...

NAION is the second most frequent cause of vision loss due to optic nerve damage, with advanced age and long-standing type 2 ...

Weight loss medications like Wegovy can be life-changing for people living with obesity or excess weight with related health ...

The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...

Use of GLP-1s, especially semaglutide and liraglutide, may increase risk for nonarteritic anterior ischemic optic neuropathy ...

Three months into taking semaglutide, I found myself staring at a sandwich I’d made for lunch, feeling absolutely zero desire ...

Table of Contents The Real Story Behind Your Changing Body Making Every Bite Count When You’re Eating Less Your Brain […] The ...

Brazilian pharmaceutical company EMS announced the release of Olire and Lirux injector pens for obesity and type 2 diabetes, ...

HYDERABAD — Dr Reddy’s Laboratories is gearing up to enter the booming global obesity drug market with a more affordable ...

Combination therapy with cagrilintide and semaglutide vs cagrilintide alone, semaglutide alone, and placebo is superior for improving weight loss results.

For a while, Danish drugmaker Novo Nordisk A/S looked unstoppable. It was at the forefront of the weight-loss injection boom as people discovered that its Ozempic shot, originally developed to treat ...